One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood.v126.23.323.323
Copy DOI Journal: Blood |  Publication Date: Dec 3, 2015 |
 Citations: 59 |
Affiliation: Memorial Sloan Kettering Cancer Center, Sarah Cannon, Agios Pharmaceuticals (United States), Cleveland Clinic, The University of Texas Southwestern Medical Center, Dana-Farber Cancer Institute, Northwestern University, The University of Texas MD Anderson Cancer Center, Massachusetts General Hospital, Harvard University, Institut Gustave Roussy, Presbyterian Hospital, New York Hospital Queens, NewYork–Presbyterian Hospital, Cornell University, Stanford University, University of Colorado Denver, Sylvester Comprehensive Cancer Center, University of MiamiSafety and Efficacy of AG-221, a Potent Inhibitor of Mutant IDH2 That Promotes Differentiation of Myeloid Cells in Patients with Advanced Hematologic Malignancies: Results of a Phase 1/2 Trial
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
